ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "pain"

  • Abstract Number: L08 • ACR Convergence 2024

    A Phase 2b, Randomized, Double-blind, Placebo-controlled, Dose-ranging and Parallel-group Study to Evaluate the Safety and Efficacy of XG005 in Subjects with Painful Osteoarthritis of the Knee

    Limin Ren1, Wenjie Zheng2, Zhenpeng Guan3, Yang Zhang4, Zeyu Huang5, Tong Li6, Yuwei Peng7, Qiuli Wu8, Wei Gou9, Wei Zhao10, Pengyan Qiao11, Xiaoli Pan12 and Guang-Liang Jiang13, 1Peking University, People’s Hospital, Rheumatology and Immunology Department, Beijing, China, 2Yantai Yuhuangding Hospital of Qingdao University, Department of Orthopedics, Yantai, China, 3Peking University, Shougang Hospital, Department of Orthopedics, Beijing, China, 4Division of Orthopaedic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China, 5West China Hospital of Sichuan University, Department of Orthopedics, Chengdu, China, 6Xiangya Hospital of Central South University, Rheumatology and Immunology Department, Changsha, China, 7PingXiang People’s Hospital, Rheumatology and Immunology Department, Pingxiang, China, 8Tianjin Medical University General Hospital, Department of Orthopedics, Tianjin, China, 9Hebei Petrochina Central Hospital, Rheumatology and Immunology Department, Langfang, China, 10Central Hospital Affiliated to Shenyang Medical College, Department of Orthopedics, Shenyang, China, 11Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Rheumatology and Immunology Department, Taiyuan, China, 12Affiliated Hospital of Zunyi Medical University, Rheumatology and Immunology Department, Zunyi, China, 13Xgene Pharmaceutical, Lexington, MA

    Background/Purpose: Osteoarthritis (OA) affects 595 million people globally; cases are projected to increase 49-95% for various joints by 2050 as populations age (GBD 2023). OA…
  • Abstract Number: L15 • ACR Convergence 2024

    LEVI-04, a Novel neurotrophin-3 Inhibitor, Substantially Improves Pain and Function Without Deleterious Effects on Joint Structure in People with Knee Osteoarthritis: A Randomized Controlled Phase II Trial

    Philip Conaghan1, Ali Guermazi2, Nathaniel Katz3, Asger Bihlet4, Dror Rom5, Michael Perkins6, Bernadette Hughes6, Claire Herholdt6, Iwona Bombelka6 and Simon Westbrook6, 1University of Leeds, Leeds, United Kingdom, 2Boston University, West Roxbury, MA, 3Rin Sof Innovation, Ltd, Boston, MA, 4NBCD A/S, Soeborg, Denmark, 5Prosoft Clinical, Chesterbrook, 6Levicept Ltd, Ramsgate, United Kingdom

    Background/Purpose: There is an urgent need for new therapies to treat OA. Excess neurotrophins (NT) are implicated in OA and other painful conditions. Previous OA…
  • Abstract Number: 0327 • ACR Convergence 2024

    Clinical and Immunological Risk Factors Associated with Fybromialgia in Patients with Idiopathic Inflammatory Myopathies

    Samuel Govea-Peláez1, Beatriz Alcalá-Carmona2, Jennifer Balderas Miranda3, Yatzil Reyna-Juárez2, María José Ostos-prado2, Nancy R Mejía-Domínguez2, Guillermo Juarez-Vega4, Jiram Torres Ruiz5 and Diana Gomez-martin6, 1INCMNSZ, Mexico City, Mexico, 2Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Distrito Federal, Mexico, 3Universidad Nacional Autónoma de México, Ciudad de México, Mexico, 4Red de Apoyo a la Investigación, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán and Universidad Nacional Autónoma de México, Mexico City, Distrito Federal, Mexico, 5INCMNSZ, Mexico, Federal District, Mexico, 6INCMNSZ, Mexico City, Federal District, Mexico

    Background/Purpose: Patients with idiopathic inflammatory myopathies (IIM) have reported chronic pain despite having normal serum muscular enzymes, physician global assessment (PhGA) and MMT8 scores, thus…
  • Abstract Number: 0797 • ACR Convergence 2024

    Associations Between Discordance of Disease Activity Indices and Quantitative Sensory Testing Measures of Nociplastic Pain in Patients with Early Rheumatoid Arthritis

    Clarice Lin1, Burcu Aydemir1, Jing Song2, Lutfiyya Muhammad3, Tuhina Neogi4, Wendy Marder5, Clifton Bingham6, Marcy Bolster7, Daniel Clauw8, Dorothy Dunlop9 and Yvonne Lee1, 1Northwestern University, Chicago, IL, 2Northwestern University, Worthington, MN, 3Northwestern Feinberg School of Medicine, Chicago, IL, 4Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 5University of Michigan, Ann Arbor, MI, 6Johns Hopkins University, Baltimore, MD, 7Massachusetts General Hospital, Boston, MA, 8University of Michigan, Whitmore Lake, MI, 9Northwestern University, New Haven, CT

    Background/Purpose: Approximately one-third of patients with rheumatoid arthritis (RA) experience nociplastic pain, a type of pain that occurs due to abnormalities in the way the…
  • Abstract Number: 1212 • ACR Convergence 2024

    Childhood Maltreatment Increases Risk of Chronic Widespread Pain: Counterfactual Analysis of UK Biobank

    Kate Timmins1, Tim Hales2 and Gary Macfarlane1, and The Consortium Against Pain inEquality Investigators and Advisory Group, 1University of Aberdeen, Aberdeen, United Kingdom, 2University of Dundee, Dundee, United Kingdom

    Background/Purpose: Adverse childhood experiences (ACEs), including maltreatment (abuse and neglect), have been associated with chronic pain, but the evidence is largely cross-sectional. Existing evidence is…
  • Abstract Number: 1335 • ACR Convergence 2024

    The Association of Patient-Reported Non-Articular Pain with Musculoskeletal Pain Diagnoses and RA Disease Activity in a Prospective Real-World Cohort of Patients with Early RA

    Charis Meng1, Margaret Butler1, Deanna Jannat-Khah1, Yvonne Lee2, Clifton Bingham3 and Vivian Bykerk1, 1Hospital for Special Surgery, New York, NY, 2Northwestern University, Chicago, IL, 3Johns Hopkins University, Baltimore, MD

    Background/Purpose: Non-articular pain (NAP) is often reported by early RA (eRA) patients, impacts RA remission (REM) but remains poorly defined and this hampers RA care.…
  • Abstract Number: 2092 • ACR Convergence 2024

    Remote-Delivered Tai Chi and Gut Microbiota in Osteoarthritis: A Randomized Mechanistic Trial

    Chenchen Wang1, Timothy McAlindon2, Meghan Short1, Mei Chung3, Ye Chen1, Albert Tai1 and Honorine Ward1, 1Tufts Medical Center, Boston, MA, 2University of Massachusets, Worchester, MA, 3Tufts Medical Center, Brighton, MA

    Background/Purpose: Previous studies show that Tai Chi achieves clinical improvement for osteoarthritis (OA) through multiple pathways. There is evidence for interaction of the gut microbiota…
  • Abstract Number: 2368 • ACR Convergence 2024

    Bimekizumab-Treated Patients with Active Psoriatic Arthritis Showed Sustained Improvements in Pain and Fatigue: Up to 2-Year Results from Two Phase 3 Studies

    Philip Mease1, William Tillett2, Maarten de Wit3, Laure Gossec4, M. Elaine Husni5, Fabian Proft6, Barbara Ink7, Rajan Bajracharya7, Jason Coarse8, Jérémy Lambert9, Laura Coates10 and Alice Gottlieb11, 1Swedish Medical Center/Providence St. Joseph Health; University of Washington School of Medicine, Seattle, WA, 2Royal National Hospital of Rheumatic Diseases; Department of Life Sciences, Centre for Therapeutic Innovation, University of Bath, Bath, United Kingdom, 3Stichting Tools, Patient Research Partner, Amsterdam, Netherlands, 4Sorbonne Université, Paris, France, 5Cleveland Clinic, Cleveland, OH, 6Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany, 7UCB Pharma, Slough, United Kingdom, 8UCB Pharma, Morrisville, NC, 9UCB Pharma, Colombes, France, 10University of Oxford, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Oxford, United Kingdom, 11Icahn School of Medicine at Mount Sinai, Department of Dermatology, Seattle, WA

    Background/Purpose: PsA significantly impacts patients' quality of life due to functional limitations, pain, and fatigue.1 Sustained relief from pain and fatigue are therefore important aims…
  • Abstract Number: 0349 • ACR Convergence 2024

    Impact of the Stanford University Chronic Pain Self-Management Education Program on Pain Severity, Pain Self-Efficacy, and Pain Disability in a Population with a High Prevalence of Arthritis

    Dina Jones1, Louise Murphy2, Ranjita Misra1, Teresa Brady3, Sijin Wen1, Dana Guglielmo4, Maura Robinson1, Samantha Shawley-Brzoska1, Chong Li1, Alison Vargovich5, Megan Burkart6 and Richard Vaglienti1, 1West Virginia University, Morgantown, WV, 2Consultant, Halifax, NS, Canada, 3Clarity Consulting and Communications, Atlanta, GA, 4Consultant, Los Angeles, CA, 5Private Practice, Buffalo, NY, 6West Virginia Unviverstiy, Morgantown, WV

    Background/Purpose: In 2021, 51.6 million (20.9%) US adults reported chronic pain (CP). Arthritis is a leading cause of CP. The Stanford Chronic Pain Self-Management Program…
  • Abstract Number: 0798 • ACR Convergence 2024

    Acute Activation of the Rat Dorsal Root Ganglion Nociceptive Cells by the Serum of Patients Suffering from Fibromyalgia

    Francisco Mercado1, Pedro Segura-Chama1, Angélica Almanza1, Laura Aline Martinez-Martinez2 and Manuel Martinez-Lavin3, 1Instituto Nacional De Psiquiatría Ramon de la Fuente Muñiz, Mexico City, Mexico, 2Rheumatology Department - National Institute of Cardiology Ignacio Chavez, Mexico City, Distrito Federal, Mexico, 3Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico

    Background/Purpose: A consistent line of investigation proposes fibromyalgia as a stress-evoked sympathetically maintained neuropathic pain syndrome. This theory posits dorsal root ganglia (DRG) at the…
  • Abstract Number: 1213 • ACR Convergence 2024

    High Prevalence of and Medication Use in Musculoskeletal and Chronic Multisite Pain in Community-Dwelling Older Adults: The Framingham Heart Study

    Sayali Dhamne1, Robert Edwards2, Emelia Benjamin3, Sarah Tilley3, Angelo Demalia4, Margaret Clancy3, Mary Molly Gheller3 and Tuhina Neogi3, 1Boston University Chobantian & Avedisian School of Medicine, Boston, MA, 2Brigham and Women's Hospital, Boston, MA, 3Boston University Chobanian & Avedisian School of Medicine, Boston, MA, 4Framingham Heart Study, Boston, MA

    Background/Purpose: Over 100 million adults have chronic pain, largely affecting older adults who often have >1 chronic pain condition. Traditionally, chronic overlapping pain conditions (COPC)…
  • Abstract Number: 1380 • ACR Convergence 2024

    Rapid, Clinically Meaningful Pain Improvements Are Associated with Improvements in Other Patient-Reported Outcomes in RA Patients Treated with Upadacitinib

    Manish Jain1, Arthur Kavanaugh2, Angela Crowley3, Avani Joshi4, Patrick Zueger5, Diane Caballero6, Andrew Garrison6 and Peter C. Taylor7, 1Endeavor Health Swedish Hospital and Captain James A, Chicago, IL, 2University of California San Diego, La Jolla, CA, 3Illinois Bone and Joint Institute, Hinsdale Orthopaedics, Hinsdale, IL, 4AbbVie, North Chicago, IL, 5AbbVie Inc, North Chicago, IL, 6AbbVie Inc., North Chicago, IL, 7University of Oxford, Oxford, United Kingdom

    Background/Purpose: Pain is a crucial symptom for patients with RA; early and effective treatment can help alleviate it.1 In this post hoc analysis, we investigated…
  • Abstract Number: 2094 • ACR Convergence 2024

    Cross-sectional Associations of Radiographic Multiple Joint Osteoarthritis and Pain with Demographic and Clinical Characteristics: Design of a Multi-modal Study in Human and Pet Dogs

    Liubov Arbeeva1, Kelly Johnson2, Serena Savage-Guin3, Tessa Walker2, Masataka Enomoto4, Christina Stevens4, Milja Koskinen4, Tracey Cole4, Savannah Aker4, Connor Thonen-Fleck4, Richard Loeser5, Jordan Renner2, Duncan Lascelles6, Yvonne Golightly7 and Amanda Nelson8, 1University of North Carolina, Chapel Hill, Carrboro, NC, 2Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, 3Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill,, Chapel Hill, NC, 4Translational Research in Pain and Comparative Pain Research and Education Center, Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, 5University of North Carolina, Chapel Hill, NC, 6North Carolina State University, Raleigh, NC, 7University of Nebraska Medical Center, Omaha, NE, 8University of North Carolina at Chapel Hill, Chapel Hill, NC

    Background/Purpose: Multiple joint osteoarthritis (MJOA) is a progressive, highly prevalent disease affecting millions of Americans and as well as pet dogs. This preliminary analysis sought…
  • Abstract Number: 2408 • ACR Convergence 2024

    Impact of Pain and Fatigue on Quality of Life Among Patients with Systemic Lupus Erythematosus

    Amanda Eudy1, Megan Clowse2, Meenakshi Jolly3, David Pisetsky4, Kai Sun5, Rebecca Sadun5, Lisa Criscione-Schreiber6, Mithu Maheswaranathan6, Jayanth Doss5 and Jennifer Rogers6, 1Duke University, Raleigh, NC, 2Duke University, Chapel Hill, NC, 3Rush University Medical Center, Chicago, 4Duke University Medical Center, Durham, NC, 5Duke University, Durham, NC, 6Duke University, Durham

    Background/Purpose: Our prior qualitative work discovered a subgroup of patients with SLE who experience persistent symptoms of fatigue and widespread pain, even on self-described “good…
  • Abstract Number: 0356 • ACR Convergence 2024

    Patient Satisfaction and Experience After a Switch to a Citrate-free High-concentration Adalimumab Biosimilar. Results from a Prospective Multicentric Real-world Study

    Hubert Marotte1, Laure Gossec2, Vered ABITBOL3, Eric SENBEL4, Guillaume BONNAUD5, Xavier ROBLIN6, Yoram BOUHNIK7, Stéphane NANCEY8, Nicolas MATHIEU9, jérôme FILIPPI10, Lucine VUITTON11, Stéphane NAHON12, Azeddine Dellal12, Alice DENIS13, Caroline HABAUZIT13, Salim BENKHALIFA13 and Guillaume BOUGUEN14, 1Université Jean Monnet, CHU Saint-Etienne, Mines Saint-Etienne, INSERM SAINBIOSE 1059, Saint-Etienne, France, 2Sorbonne Université, Paris, France, 3Cochin University Hospital, Paris, France, 4Medical practice, Marseille, Marseille, France, 5Ambroise Paré Clinic, Toulouse, France, 6Saint-Etienne University Hospital, Saint-Etienne, France, 7Institut des MICI, Paris IBD Center, Neuilly-Sur-Seine, France, 8Hospices Civils de Lyon, Lyon, France, 9Clinic of Cèdres, Echirolles, France, 10Saint-Jean Clinic, Cagnes sur Mer, France, 11Besançon university hospital, Besançon, France, 12Groupe Hospitalier Intercommunal Le Raincy-Montfermeil, Montfermeil, France, 13Celltrion Healthcare France, Issy Les Moulineaux, France, 14Rennes University Hospital, Rennes, France

    Background/Purpose: Biosimilars (BioS) are cost-effective alternatives to reference products for patients with chronic inflammatory rheumatic diseases (CIRD) and inflammatory bowel diseases (IBD), but treatment adherence…
  • 1
  • 2
  • 3
  • …
  • 37
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology